secwatch / observer
8-K filed November 8, 2023, 6:59 PM ET ticker PIII CIK 0001832511
earnings confidence high sentiment positive materiality 0.75

P3 Health Partners Q3 revenue $288.4M (+16% YoY); net loss narrows; guides for positive 2024 Adj EBITDA

P3 Health Partners Inc.

2023-Q3 EPS reported -$0.41 revenue$919,514,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

P3 Health Partners Inc. reported three and nine months ended September 30, 2023 results: revenue $288.4 million, net income Net loss was $37.3 million. Guidance reaffirmed.

Period
three and nine months ended September 30, 2023
Revenue
$288.4 million
Net income
Net loss was $37.3 million
Guidance
reaffirmed
Result
reported results
Exact text from the filing
preliminary 2024 full-year Adjusted EBITDA guidance of $20 million to $40 million,” said Dr. Sherif Abdou, CEO of P3. Third-Quarter 2023 Financial Results • Total revenue was $288.4 million, an increase of 16% compared to $248.3 million in the third quarter of the prior year. Net loss was $37.3 million, an increase of approximately 43% compared to a net loss of
View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR
accession 0001628280-23-037818
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.